The search for a molecular biomarker in malignant mesothelioma is as old as its first proven effective therapy (1,2). A definitive diagnostic biomarker could aid in establishing the diagnosis of malignant mesothelioma in patient.

Additional Metadata
Persistent URL dx.doi.org/10.21037/jtd.2018.03.128, hdl.handle.net/1765/111998
Journal Journal of Thoracic Disease
Citation
Cornelissen, R, & Aerts, J.G.J.V. (2018). Biomarkers in malignant mesothelioma-an unfulfilled need or a waste of resources?. Journal of Thoracic Disease, 10, S1084–S1087. doi:10.21037/jtd.2018.03.128